NOT KNOWN FACTUAL STATEMENTS ABOUT IL-2 THERAPY FOR MELANOMA

It is acceptable to consider that Denileukin Diftitox has an effect on nonmalignant IL-2R+ lymphocytes which have been needed to assist battle most cancers distribute. Reports have suggested that Tregs are preferentially depleted as compared to effector cells [seventy seven, seventy eight].Theoretically, IL-2 has a synergistic effect with cancer va